Olmesartan Medoxomil Amlodipine And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 33342-243

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil Amlodipine And Hydrochlorothiazide (NDC 33342-243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

931 (Olme Medo Amlo Hctz 20 mg 5mg 12 5 mg 30s)

This is a description of a medication containing Olmesartan Medoxomil, Amlodipine Besylate, and Hydrochlorothiazide. Each film-coated tablet contains Olmesartan Medoxomil 20 mg, Amlodipine Besylate 6.9 mg (equivalent to 5 mg Amlodipine), and Hydrochlorothiazide 12.5 mg. The usual dosage and prescribing information can be found in the package insert. The medication should be stored at 20° to 25°C, with excursions permitted to 15° to 30°C. This medication is manufactured by Macleods Pharma USA, Inc.*

FDA Label Image

561 (Olme Medo Amlo Hctz 40 mg 10mg 12 5 mg 30s)

This is a description of a medication with NDC 33342-24607. It is a tablet containing Olmesartan Medoxomil, Amlodipi, and Hydrochlorothiazide. Each film-coated tablet has specific dosages of these active ingredients. The usual dosage information can be found in the package insert. The medication should be stored at a temperature range of 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The tablets are manufactured by Macleods Pharma USA, Inc.*

FDA Label Image

974 (Olme Medo Amlo Hctz 40 mg 10mg 25 mg 30s)

This is a description of a medication containing Amlodipine Besylate, USP and Olmesartan Medoxomil, USP. The medication is in tablet form with each film coated tablet containing Olmesartan Medoxomil, USP 40 mg. The typical dosage is mentioned in the package insert. The product is manufactured by Macloods Pharma USA, Inc., and Madeods Pharmaceuticals Ltd in India. It is advised to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F).*

FDA Label Image

866 (Olme Medo Amlo Hctz 40 mg 5mg 12 5 mg 30s)

The text appears to be a description of a medication. It states that each film-coated tablet contains 40 mg of Olmesartan Medoxomil, USP along with other components like Amlodipine Besylate and Olmesartan Hydrochlorothiazide. It provides information on the usual dosage and storage conditions for the tablets. The manufacturer is mentioned as Macleods Pharma USA, Inc. with an address in Princeton, NJ, and Daman, India.*

FDA Label Image

947 (Olme Medo Amlo Hctz 40 mg 5mg 25 mg 30s)

Each film coated tablet contains Olmesartan Medoxomil, USP 40 mg and Amlodipine Besylate, USP 6.9 mg, equivalent to 5 mg Amlodipine. It also contains Olmesartan Hydrochlorothiazide, USP 25 mg. The usual dosage should be checked in the package insert for full prescribing information. Store between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). This medication is manufactured by Zydus Pharmaceuticals Ltd. and is available in a pack containing 30 tablets.*

FDA Label Image

Olme-medo-amlo-hctz-str-1.jpg (Olme Medo Amlo Hctz Str 1)

FDA Label Image

Olme-medo-amlo-hctz-str-2.jpg (Olme Medo Amlo Hctz Str 2)

FDA Label Image

Olme-medo-amlo-hctz-str-3.jpg (Olme Medo Amlo Hctz Str 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.